What does the evidence currently show Data from randomized controlled trials (RCTs) and meta-analysis of RCTs show that semaglutide and tirzepatide (two types of GLP-1 medications) reduce body weight, waist circumference, and improve major cardiometabolic risk biomarkers (e.g
The bottom line After having a baby, its normal to want to lose any lingering pregnancy weight
Ipamorelin is a growth hormone-releasing peptide (GHRP), and some of the early research on animals is intriguingbut the studies are limited, and ipamorelin hasnt yet been approved for any medical use
The trade-offs: higher cost, less dose flexibility, and dependence on manufacturer supply
Commercial products such as Ozempic, Wegovy, Mounjaro, and Zepbound have pre-filled pens with fixed doses
Cabe destacar que la sibutramina, que formaba parte de medicamentos recetados para el tratamiento de la obesidad, fue retirada del mercado de la Unin Europea en 2010 debido a sus asociaciones con efectos adversos cardiovasculares graves, segn la nota informativa de la AEMPS publicada el 21 de enero de ese ao
